Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About LRCX Interactive Breakdown Better Bets vs. LRCX Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Lam Research (LRCX)

Market Price (10/31/2025): $162.5 | Market Cap: $205.5 Bil
Sector: Information Technology | Industry: Semiconductor Materials & Equipment

Lam Research (LRCX)

Market Price (10/31/2025): $162.5
Market Cap: $205.5 Bil
Sector: Information Technology
Industry: Semiconductor Materials & Equipment

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 26%		 Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is 0.0%		 Stock price has recently run up significantly
6M Rtn6 month market price return is 125%, 12M Rtn12 month market price return is 113%
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 33%		  Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 59%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 33%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 28%, CFO LTM is 6.4 Bil, FCF LTM is 5.6 Bil		  
3 Low stock price volatility
Vol 12M is 48%		  
0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 26%
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 33%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 33%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 28%, CFO LTM is 6.4 Bil, FCF LTM is 5.6 Bil
3 Low stock price volatility
Vol 12M is 48%
4 Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is 0.0%
5 Stock price has recently run up significantly
6M Rtn6 month market price return is 125%, 12M Rtn12 month market price return is 113%
6 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 59%

Market Valuation & Key Metrics

LRCXS&P 500
REVENUE GROWTHGOOD
Rev LTM ($ Bil)19.6
Rev Chg Q27.7%6.4%
Rev Chg LTM25.7%5.4%
Rev Chg 3Y Avg4.0%5.3%
PROFITABILITYVERY GOOD
Op Inc LTM ($ Bil)6.5
CFO LTM ($ Bil)6.4
Net Inc LTM ($ Bil)5.8
Op Mgn LTM33.0%18.7%
CFO/Rev LTM32.6%20.4%
Net Inc Mgn29.7%12.8%
VALUATIONHIGH
P/S10.53.2
P/CFO32.215.5
P/FCF37.020.6
P/E35.423.6
STABILITYVERY GOOD
Debt/Equity0.020.21
Cash/Assets0.310.07

LRCX Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The 125.5% change in LRCX stock from 5/1/2025 to 10/30/2025 was primarily driven by a 78.0% change in the company's P/E Multiple.

501202510302025Change
Stock Price ($)71.41161.01125.47%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)17135.7119591.7914.33%
Net Income Margin (%)27.19%29.66%9.09%
P/E Multiple19.6835.0478.04%
Shares Outstanding (Mil)1283.781264.451.51%
Cumulative Contribution125.42%

LTM = Last Twelve Months as of date shown
The 112.8% change in LRCX stock from 10/30/2024 to 10/30/2025 was primarily driven by a 44.6% change in the company's P/E Multiple.

1030202410302025Change
Stock Price ($)75.65161.01112.84%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)15591.3019591.7925.66%
Net Income Margin (%)26.02%29.66%13.98%
P/E Multiple24.2335.0444.62%
Shares Outstanding (Mil)1299.241264.452.68%
Cumulative Contribution112.69%

LTM = Last Twelve Months as of date shown
The 311.3% change in LRCX stock from 10/31/2022 to 10/30/2025 was primarily driven by a 217.2% change in the company's P/E Multiple.

1031202210302025Change
Stock Price ($)39.15161.01311.29%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)17996.6919591.798.86%
Net Income Margin (%)26.96%29.66%10.02%
P/E Multiple11.0535.04217.20%
Shares Outstanding (Mil)1368.911264.457.63%
Cumulative Contribution308.90%

LTM = Last Twelve Months as of date shown

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
LRCX Return64%54%-41%89%-7%125%456%
Peers Return35%56%-27%52%2%49%252%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
LRCX Win Rate67%67%33%58%42%56% 
Peers Win Rate60%63%38%62%45%51% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
LRCX Max Drawdown-36%0%-56%-1%-10%-18% 
Peers Max Drawdown-39%-0%-44%-5%-10%-25% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: AMAT, KLAC, ADI, ICHR, LRCX. See LRCX Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

Unique KeyEventLRCXS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-56.8%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven131.7%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven423 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-45.0%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven81.8%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven116 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-46.1%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven85.5%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven259 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-75.0%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven299.9%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven2011 days1480 days

Compare to AMAT, KLAC, ADI, ICHR, LRCX


In The Past

Lam Research's stock fell -56.8% during the 2022 Inflation Shock from a high on 1/14/2022. A -56.8% loss requires a 131.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Lam Research (LRCX)

Better Bets than Lam Research (LRCX)

 LRCXBetter Performance than LRCX
MetricValueIndustry (Semiconductor Materials & Equi)
Rev Chg LTM25.7%NVMI (43.7%), CAMT (27.9%), AMBA (57.9%), SMTK (125.6%)
Rev Chg 3Y Avg4.0%AMAT (4.4%), KLAC (10.4%), ENTG (10.9%), NVMI (17.9%), MKSI (8.4%)
Op Mgn LTM33.0%KLAC (41.2%)
CFO/Rev LTM32.6%KLAC (33.6%)
FCF/Rev LTM28.3%KLAC (30.8%)
Total Yield3.4%AMAT (4.4%), MKSI (3.5%), ENPH (5.0%), ACMR (4.3%), ACLS (6.1%)
 LRCXBetter Performance than LRCX
MetricValueAll Other Sectors
Rev Chg LTM25.7%LLY (36.8%), APP (48.2%), HOOD (59.6%), WELL (32.6%), MELI (35.8%)
Rev Chg 3Y Avg4.0%GOOGL (11.0%), AMZN (11.3%), META (17.3%), TSLA (9.3%), JPM (13.5%)
Op Mgn LTM33.0%META (43.2%), LLY (43.0%), V (66.5%), MA (58.0%), PM (37.1%)
CFO/Rev LTM32.6%GOOGL (39.3%), META (56.8%), V (60.4%), MA (53.3%), ABBV (33.1%)
FCF/Rev LTM28.3%V (56.8%), MA (49.2%), ABBV (31.3%), APP (53.7%), RY (131.7%)
Total Yield3.4%GOOGL (3.9%), META (3.8%), JPM (6.6%), WMT (3.5%), V (3.7%)
 Best Bets In Information Technology Sector
 LRCXVRSN NVDA RMBS QLYS ADBE YOU GEN IDCC DBX KLAC
What You Pay           
P/E35.027.157.150.724.320.616.527.022.216.139.5
P/EBIT30.419.649.043.222.716.519.69.917.713.732.4
What You Get           
Rev Chg Q27.7%7.3%55.6%22.7%10.3%10.7%17.5%30.3%34.5%-1.4%23.6%
Rev Chg LTM25.7%5.5%71.6%31.0%9.6%10.7%19.8%10.6%21.8%-0.0%23.9%
Rev Chg 3Y Avg4.0%5.2%92.0%17.3%12.5%10.5%35.5%14.8%23.3%4.1%10.4%
FCF/Rev 3Y Avg29.3%57.4%41.3%39.3%39.0%37.7%37.3%35.9%35.1%32.9%31.1%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 24%, alpha of 2.9%, and sharpe of 1.04

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Lam Research Earnings Notes  
2Should You Buy Lam Research Stock?Buy or Fear 
3Ten-Year Tally: LRCX Returns $30 Bil to Shareholders  
4Lam Research Stock Surged 100%, Here's Why  
5KLAC Looks Smarter Buy Than Lam Research StockActionable 
6Lam Research Stock Surged 100%, Here's Why  
7Lam Research Stock Jumped 14% in a Week, What Now?Return 
8Is KLA a Better Long-Term Bet Than Lam Research?Counter-Intuitive Comparisons 
9Day 5 of Gains Streak for Lam Research Stock with 15% Return (vs. 105% YTD) [10/2/2025]Notification 
10Day 14 of Gains Streak for Lam Research Stock with 36% Return (vs. 84% YTD) [9/22/2025]Notification 
11ARTICLES  
12Is Lam Research a Better Buy Than Teradyne? October 31st, 2025
13Stronger Bet Than Teradyne Stock: LRCX, AMAT Deliver More October 30th, 2025
14Buy or Sell Lam Research Stock? October 28th, 2025
15Lam Research Stock Pays Out $30 Bil – Investors Take Note October 24th, 2025
16How To Trade Lam Research Stock Ahead of Its Upcoming Earnings? October 20th, 2025
Title
0DASHBOARDS
1Is Lam Research a Better Buy Than Teradyne?
2Stronger Bet Than Teradyne Stock: LRCX, AMAT Deliver More
3Buy or Sell Lam Research Stock?
4Lam Research Stock Pays Out $30 Bil – Investors Take Note
5How To Trade Lam Research Stock Ahead of Its Upcoming Earnings?
6ARTICLES
7Lam Research Earnings Notes
8Should You Buy Lam Research Stock?
9Ten-Year Tally: LRCX Returns $30 Bil to Shareholders
10Lam Research Stock Surged 100%, Here's Why
11KLAC Looks Smarter Buy Than Lam Research Stock
12Lam Research Stock Surged 100%, Here's Why
13Lam Research Stock Jumped 14% in a Week, What Now?
14Is KLA a Better Long-Term Bet Than Lam Research?
15Day 5 of Gains Streak for Lam Research Stock with 15% Return (vs. 105% YTD) [10/2/2025]
16Day 14 of Gains Streak for Lam Research Stock with 36% Return (vs. 84% YTD) [9/22/2025]

Trade Ideas

Select past ideas related to LRCX. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADBE_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025ADBEAdobeMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.2%-4.2%-6.7%
CRM_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025CRMSalesforceMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		6.1%6.1%-0.6%
MPWR_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025MPWRMonolithic Power SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		18.8%18.8%-1.8%
POWI_9262025_Dip_Buyer_High_CFO_Margins_ExInd_DE09262025POWIPower IntegrationsDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap		3.7%3.7%-13.4%
ROP_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025ROPRoper TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-10.5%-10.5%-10.5%
LRCX_2282025_Monopoly_xInd_xCD_Getting_Cheaper02282025LRCXLam ResearchMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		31.2%110.9%-22.8%
LRCX_12312022_Dip_Buyer_FCFYield12312022LRCXLam ResearchDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		53.9%88.6%-1.4%
LRCX_4302022_Dip_Buyer_FCFYield04302022LRCXLam ResearchDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-12.3%14.2%-31.9%
LRCX_9302018_Dip_Buyer_FCFYield09302018LRCXLam ResearchDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		19.5%56.0%-18.2%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADBE_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025ADBEAdobeMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-4.2%-4.2%-6.7%
CRM_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025CRMSalesforceMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		6.1%6.1%-0.6%
MPWR_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025MPWRMonolithic Power SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		18.8%18.8%-1.8%
POWI_9262025_Dip_Buyer_High_CFO_Margins_ExInd_DE09262025POWIPower IntegrationsDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap		3.7%3.7%-13.4%
ROP_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025ROPRoper TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-10.5%-10.5%-10.5%
LRCX_2282025_Monopoly_xInd_xCD_Getting_Cheaper02282025LRCXLam ResearchMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		31.2%110.9%-22.8%
LRCX_12312022_Dip_Buyer_FCFYield12312022LRCXLam ResearchDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		53.9%88.6%-1.4%
LRCX_4302022_Dip_Buyer_FCFYield04302022LRCXLam ResearchDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-12.3%14.2%-31.9%
LRCX_9302018_Dip_Buyer_FCFYield09302018LRCXLam ResearchDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		19.5%56.0%-18.2%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Lam Research

Financials

LRCXAMATKLACADIICHRMedian
NameLam Rese.Applied .KLA Analog D.Ichor  
Mkt Price161.01232.551,214.41232.9022.81232.55
Mkt Cap203.6185.6160.3115.10.8160.3
Rev LTM19,59228,61312,15610,38792912,156
Op Inc LTM6,4668,6235,0142,630-85,014
FCF LTM5,5505,8233,7423,678-193,742
FCF 3Y Avg4,9646,4573,3673,439273,439
CFO LTM6,3847,7054,0824,162174,162
CFO 3Y Avg5,5317,7883,6874,310524,310

Growth & Margins

LRCXAMATKLACADIICHRMedian
NameLam Rese.Applied .KLA Analog D.Ichor  
Rev Chg LTM25.7%6.6%23.9%7.1%15.4%15.4%
Rev Chg 3Y Avg4.0%4.4%10.4%-0.6%-6.0%4.0%
Rev Chg Q27.7%7.7%23.6%24.6%18.2%23.6%
QoQ Delta Rev Chg LTM6.3%1.9%5.2%5.8%4.2%5.2%
Op Mgn LTM33.0%30.1%41.2%25.3%-0.8%30.1%
Op Mgn 3Y Avg30.2%29.4%38.8%27.5%0.6%29.4%
QoQ Delta Op Mgn LTM1.0%0.5%1.1%1.8%-0.3%1.0%
CFO/Rev LTM32.6%26.9%33.6%40.1%1.8%32.6%
CFO/Rev 3Y Avg32.5%28.5%34.1%39.5%5.6%32.5%
FCF/Rev LTM28.3%20.4%30.8%35.4%-2.0%28.3%
FCF/Rev 3Y Avg29.3%23.7%31.1%31.5%3.0%29.3%

Valuation

LRCXAMATKLACADIICHRMedian
NameLam Rese.Applied .KLA Analog D.Ichor  
Mkt Cap203.6185.6160.3115.10.8160.3
P/S10.46.513.211.10.810.4
P/EBIT30.420.332.443.4-88.830.4
P/E35.027.239.558.8-37.735.0
P/CFO31.924.139.327.745.731.9
Total Yield3.4%4.4%3.1%3.3%-2.7%3.3%
Dividend Yield0.6%0.7%0.6%1.6%0.0%0.6%
FCF Yield 3Y Avg4.4%4.4%3.6%3.2%1.9%3.6%
D/E0.00.00.00.10.20.0
Net D/E-0.0-0.00.00.00.10.0

Returns

LRCXAMATKLACADIICHRMedian
NameLam Rese.Applied .KLA Analog D.Ichor  
1M Rtn20.2%13.6%12.6%-5.2%30.2%13.6%
3M Rtn70.1%29.5%38.5%4.1%15.3%29.5%
6M Rtn125.5%57.0%80.4%21.2%15.1%57.0%
12M Rtn112.8%26.8%77.2%2.9%-19.3%26.8%
3Y Rtn311.3%170.7%295.9%72.2%-10.3%170.7%
1M Excs Rtn11.1%5.1%5.9%-4.3%13.5%5.9%
3M Excs Rtn58.0%20.2%27.9%-3.9%8.3%20.2%
6M Excs Rtn103.7%35.3%58.7%-0.5%-6.6%35.3%
12M Excs Rtn98.5%9.6%64.7%-14.2%-35.2%9.6%
3Y Excs Rtn261.5%96.3%234.2%-9.0%-82.2%96.3%

Comparison Analyses

Financials

$ Mil | FY: 6/292026Q12025Q42025Q32025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q2
Period End9/28/20256/29/20253/30/202512/29/20249/29/20246/30/20243/31/202412/24/20239/24/20236/25/20233/26/202312/25/2022
Filing Date10/24/20258/11/20254/25/20251/31/202510/28/20248/29/20244/29/20241/29/202410/23/20238/15/20234/24/20231/30/2023
Key Financials Quarterly            
Total Revenue5,3245,1714,7204,3764,1683,8723,7943,7583,4823,2073,8705,278
Ebitda2,0031,9201,6791,4901,4341,2891,2301,2241,1611,0001,0781,784
Operating Income1,8291,7411,5621,3341,2641,1261,0721,0591,0258569831,680
Net Income1,5691,7201,3311,1911,1161,0209669548878038141,469
EPS1.241.351.040.930.860.780.740.720.670.600.601.08
Key Financials TTM            
Total Revenue TTM19,59218,43617,13616,20915,59114,90514,24114,31715,83617,42918,85719,048
Ebitda TTM7,0926,5235,8925,4435,1774,9054,6164,4635,0235,6386,1316,319
Operating Income TTM6,4665,9015,2864,7964,5214,2824,0133,9234,5445,2175,8406,049
Net Income TTM5,8105,3584,6584,2944,0573,8283,6103,4583,9724,5114,9175,125
Growth Rates Quarterly            
Total Revenue Growth27.7%33.6%24.4%16.4%19.7%20.7%-2.0%-28.8%-31.4%-30.8%-4.7%24.9%
EBITDA Growth39.7%49.0%36.5%21.7%23.4%28.9%14.1%-31.4%-34.6%-33.0%-14.8%20.2%
Operating Income Growth44.7%54.7%45.6%26.0%23.3%31.5%9.1%-37.0%-39.6%-42.1%-17.6%25.6%
Net Income Growth40.5%68.6%37.8%24.8%25.8%27.1%18.7%-35.0%-37.8%-33.6%-20.3%22.9%
Margins Quarterly            
EBITDA Margin37.6%37.1%35.6%34.0%34.4%33.3%32.4%32.6%33.4%31.2%27.9%33.8%
Operating Income Margin34.4%33.7%33.1%30.5%30.3%29.1%28.3%28.2%29.4%26.7%25.4%31.8%
Net Income Margin29.5%33.3%28.2%27.2%26.8%26.4%25.5%25.4%25.5%25.0%21.0%27.8%
Cash & Debt            
Total Cash6,6936,3915,4515,6656,0675,8485,6725,6385,1575,3755,3694,588
Total Debt4,4844,4854,4844,9824,9844,9834,9834,9844,9845,0125,0055,003
Net Debt / (Cash)-2,209-1,906-966-683-1,084-865-689-654-172-363-364415
Cash Flows Quarterly            
FCF from Operations1,7792,5541,3097421,5688621,3851,4549511,1231,7261,140
Cash Flows TTM            
FCF from Operations TTM6,3846,1734,4824,5585,2704,6524,9135,2544,9415,1794,5003,531
Returns to Shareholders Quarterly            
Dividends292295296298261261263264230232234236
Share Repurchases9761,292435698997374981645843869582456
Return on Invested Capital (ROIC) Quarterly            
ROIC-----------1438.1%
Return on Invested Capital (ROIC) TTM            
ROIC TTM-----------1286.7%

Segment Financials

Revenue by Segment

$ Mil20252024202320222021
Manufacturing and servicing of wafer processing semiconductor manufacturing equipment14,90517,42917,22714,62610,045
Total14,90517,42917,22714,62610,045


Price Behavior

LRCX Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta3.541.801.551.761.761.86
Up Beta5.381.251.861.771.681.83
Down Beta5.620.180.671.831.761.68
Up Capture565%390%256%274%358%1956%
Bmk +ve Days13233574144420
Stock +ve Days17314280139392
Down Capture7%108%80%125%136%110%
Bmk -ve Days8192952107330
Stock -ve Days4112246111358

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity32,402,751
Short Interest: % Change Since 93020259.0%
Average Daily Volume12,524,148
Days-to-Cover Short Interest2.59
Basic Shares Quantity1,264,446,000
Short % of Basic Shares2.6%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
10/22/20254.5%13.7% 
7/30/2025-4.3%-3.2%5.0%
4/23/20256.2%7.4%23.7%
1/29/20257.4%9.0%2.1%
10/23/20245.1%4.9%0.4%
7/31/2024-9.9%-18.8%-13.5%
4/24/20241.9%-1.9%8.3%
1/24/20242.1%-2.7%9.5%
...
SUMMARY STATS   
# Positive131414
# Negative111010
Median Positive4.9%7.1%9.3%
Median Negative-2.9%-2.9%-3.9%
Max Positive9.3%16.8%39.7%
Max Negative-9.9%-18.8%-13.5%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251024202510-Q 9/28/2025
6302025811202510-K 6/29/2025
3312025425202510-Q 3/30/2025
12312024131202510-Q 12/29/2024
93020241028202410-Q 9/29/2024
6302024829202410-K 6/30/2024
3312024429202410-Q 3/31/2024
12312023129202410-Q 12/24/2023
93020231023202310-Q 9/24/2023
6302023815202310-K 6/25/2023
3312023424202310-Q 3/26/2023
12312022130202310-Q 12/25/2022
93020221024202210-Q 9/25/2022
6302022824202210-K 6/26/2022
3312022426202210-Q 3/27/2022
12312021201202210-Q 12/26/2021

Insider Activity

Expand for More

 

External Quote Links


Prefer one of these to Trefis? Tell us why.